Students Taken Covaxin Jab Skeptical About Studying Abroad
Students who applied abroad and administered with Bharat Biotech’s Covaxin are skeptical about whether they will be eligible for air travel to the UK or the US. The dilemma is due to Covaxin’s pending approval before the WHO. Students said, had they knew about the issue they would have waited for Pfizer or Johnson & Johnson. Counsellor Alok Bansal also raised the Covishield’s 90-day gap policy between two doses.
Tags: Covaxin, Vaccination Drive, pandemic, Covishield vaccine
Courtesy: Times of India
India To Study Efficacy Of Single Covishield Shot, Mixing Of Vaccines
The Centre is looking to form new strategies to ramp up the vaccination process as it has allowed the studies wherein mixing of vaccines and the potency of single dose of Covishield are being tested. However, mixing of different vaccines will be done only after an in-depth research. Besides, a new App will be linked to CoWin so that vaccinated individuals can report in case of any side-effect.
Tags: Coronavirus Vaccines, Vaccination Drive, Covishield vaccine, Covaxin
Courtesy: NDTV
B'luru Doctor Busted For Stealing Vaccine From PHC And Using Illegally
The Bengaluru police on May 20 arrested a doctor at a Public Health Centre in Manjunathnagar for vaccinating people at her associate’s house in Bengaluru. The accused identified as Dr Pushpita (25) a medical officer with her associate Prema (34) were reportedly charging Rs 500 for one Covishield vaccine shot. The police said that “The doctor used to get the vials from the PHC in a frozen vial carrier.”
Tags: Karnataka, Covishield vaccine, bengaluru, Manjunathnagar
Courtesy: Indian Express
India Receives Its First COVID-19 Emergency Supplies From US
Among the several consignments, India received its first supply of COVID-19 emergency aid from the US on April 30 in two military aircrafts. Reportedly, the batch consists stock of 36 millipore filters in order to manufacture five lakh doses of Covishield vaccines. Besides, 17 oxygen generators plants have been received. However, the next consignment is supposed to arrive on May 3 along with supplies from the Gulf countries.
Tags: US, COVID-19 Aid, Covishield vaccine, Oxygen Generators, Covid-19
Courtesy: The Tribune
Vaccine Maker SII's CEO Adar Poonawalla Given Y-Security Amid Threats
Vaccine-maker Serum Institute of India (SII)'s CEO Adar Poonawalla has been granted Y-category security by the Home Ministry. Based on the threat perception report and to be handled by the CRPF, the security cover will include 11 personnel comprising CRPF commandos and policemen. SII is responsible for manufacturing 'Covishield' vaccine, whose rate was recently cut for states, from Rs 400 to Rs 300, after Poonawalla announced it on April 28… read-more
Tags: SII, Adar Poonawalla, Covishield vaccine, Y-Category security
Courtesy: The Times of India
Doses given 2-3 months apart are more effective, says SII's CEO Adar Poonawalla
CEO of Serum Institute of India, Adar Poonawalla said if a gap of 2-3 months is kept between the first and second dose then the efficacy of Covishield increases to up to 90%. And if the gap is increased for other vaccines it will yield similar results. In March, India decided to increase the interval between the two shots to 8 weeks on the recommendation by the National Expert Group.
Tags: Covishield vaccine, Covid Vaccination, Covaxin, SECOND WAVE
Courtesy: India Today
Delhi CM Arvind Kejriwal, His Parents Receive COVID-19 Vaccine Shot
Delhi CM Arvind Kejriwal on March 4 received his first shot of COVID-19 vaccine. Kejriwal's parents - Govind Ram Kejriwal and Gita Devi - were also inoculated along with him. After taking the jab, Kejriwal said, "We don't have any problems (after vaccination)." Urging everyone to take the vaccine, the Delhi CM has assured to increase the vaccination centres in the state "if needed". He was administered indigenously developed 'Covishield'.
Tags: Delhi, Arvind Kejriwal, LNJP Hospital, Covishield vaccine
Courtesy: NDTV
Govt Planning To Offer COVID Vaccines At Pvt Hospitals For Rs 250/Jab
The Health Ministry is supposedly planning to offer COVID-19 vaccines at private hospitals for inoculating people above 60 and over 45 having comorbidities from March 1. As a part of the upcoming vaccination drive, the vaccines will be available at Rs 250/dose in 20,000 hospitals. Initially, while only Serum Institue of India's Covisheld will be available at private hospitals, around 1,500 NABH and NBE accredited hospitals have sought… read-more
Tags: Covid Vaccination, Covid-19 Vaccine, Covishield vaccine, Serum Institute of India
Courtesy: The New Indian Express
Pune SII Fire: CEO Adar Poonawalla Estimates Rs 1,000 Cr Loss
A day after the fire outbreak at its Pune-based plant, the Serum Institute of India CEO Adar Poonawalla has admitted a financial loss of Rs 1,000 crore. Adar said, "The fire has damaged machinery installed for rotavirus and BCG vaccine production." However, has assured that the production facility of COVID-19 vaccine - Covishield - has not been affected. Moreover, three to four floors of the SII facility were damaged.
Tags: Fire at SII, SII, Adar Poonawalla, Covishield vaccine
Courtesy: Deccan Herald
Pune: Fire Breaks Out At New SII Campus At Manjari
Serum Institute of India's premises at Pune's Manjari witnessed a fire breakout in its new building on January 21. As per the fire brigade officials, 10 fire tenders have been deployed at the site, where the incident happened around 2:30 pm. However, officials confirmed that the affected building was "not directly connected to Covishield manufacturing". Meanwhile, the evacuation process is underway, and no casualties have been reported until… read-more
Tags: Serum Institute of India, Pune, Manjari, Covishield vaccine
Courtesy: The Indian Express